Skip to menu Skip to content Skip to footer

A novel recombinant Hepatitis D virus-like particle vaccine elicits human MHC calss 1 restricted CTL responses, which protect against establishment and growth of tumours expressing the E7 oncoprotein (1998-1999)

Abstract

A novel recombinant Hepatitis D virus-like particle vaccine elicits human MHC calss 1 restricted CTL responses, which protect against establishment and growth of tumours expressing the E7 oncoprotein associated with cervical cancer

Experts

Emeritus Professor Robert Tindle

Emeritus Professor
School of Chemistry and Molecular Biosciences
Faculty of Science
Robert Tindle
Robert Tindle